CLINICAL_TRIALS
trial_result
· 2021-07-02
Clinical Trial Update: A Study of Lasmiditan (LY573144) Over Four Migraine Attacks [Phase 3]
Summary
Phase 3 trial update on lasmiditan (LY573144) across four migraine attacks with completed results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2021-07-02